Refeeding syndrome
Editor-In-Chief: Prab R Tumpati, MD
Obesity, Sleep & Internal medicine
Founder, WikiMD Wellnesspedia &
W8MD's weight loss doctor NYC
Philadelphia GLP-1 weight loss and GLP-1 clinic NYC
| Refeeding syndrome | |
|---|---|
| |
| Synonyms | |
| Pronounce | N/A |
| Specialty | N/A |
| Symptoms | Electrolyte imbalance, hypophosphatemia, hypokalemia, hypomagnesemia, edema, cardiac arrhythmias, seizures |
| Complications | Heart failure, respiratory failure, rhabdomyolysis, delirium |
| Onset | Within 4 days of refeeding |
| Duration | Variable, depending on management |
| Types | N/A |
| Causes | Rapid refeeding after periods of malnutrition or starvation |
| Risks | Anorexia nervosa, chronic alcoholism, prolonged fasting, malabsorption syndromes, cancer |
| Diagnosis | Clinical assessment, monitoring of electrolyte levels |
| Differential diagnosis | Electrolyte imbalance, heart failure, sepsis |
| Prevention | Gradual refeeding, monitoring of electrolytes |
| Treatment | Electrolyte replacement, careful monitoring, gradual increase in caloric intake |
| Medication | N/A |
| Prognosis | Good with appropriate management |
| Frequency | Common in at-risk populations |
| Deaths | Rare with proper treatment |
Refeeding syndrome (RFS) is a potentially serious metabolic condition that can arise when nutrition is reintroduced to severely malnourished individuals. This syndrome is characterized by an imbalance of water-electrolytes, glucose intolerance, cardiac arrhythmias, and diarrhea, typically occurring within the first five days of refeeding.[1]
Understanding Refeeding Syndrome[edit]
The hallmark of refeeding syndrome is a shift in fluids and electrolytes in a malnourished individual who receives nutritional supplementation. This shift can lead to severe complications such as heart failure, respiratory failure, and death if not recognized and managed promptly.
Causes and Risk Factors[edit]
The primary cause of RFS is the reintroduction of glucose, or carbohydrates, to a severely malnourished individual. Risk factors include prolonged fasting, low BMI, significant unintentional weight loss, and underlying chronic diseases such as cancer and chronic gastrointestinal diseases.[2]
Symptoms[edit]
Symptoms of RFS can vary widely and may include fatigue, muscle weakness, seizures, heart failure, and even coma.
Diagnosis[edit]
The diagnosis of RFS is often clinical, made by observing the patient's response to nutritional reintroduction. However, blood tests are essential to monitor electrolyte levels, especially phosphorus, magnesium, and calcium.[3]
Management[edit]
Management of RFS requires careful monitoring and correction of electrolyte imbalances, along with gradual, controlled reintroduction of nutrients. In some cases, intravenous electrolyte replacement may be necessary.[4]
See Also[edit]
This WikiMD article can only be edited by registered and verified editors. You can log in or register.
- ↑ Mehanna, HM."Refeeding syndrome: what it is, and how to prevent and treat it".BMJ.2008;336(7659)
- 1495-1498.doi:10.1136/bmj.a301.
- ↑ Rio, A."Refeeding syndrome: clinical and nutritional relevance".Endocrinol Diabetes Nutr.2018;65(6)
- 320-327.doi:10.1016/j.endinu.2018.01.009.
- ↑ Refeeding Syndrome. UpToDate.Accessed 2023-05-18.
- ↑ Sriram, K."The refeeding syndrome and its current clinical implications".JPEN J Parenter Enteral Nutr.2013;37(4)
- 462-70.doi:10.1177/0148607113476583.
Sponsored Health Resource
W8MD Weight Loss, Sleep & MedSpa
Looking for physician-supervised weight loss, semaglutide, tirzepatide, or GLP-1 receptor agonist options? W8MD helps eligible patients in New York City, Brooklyn, New Jersey, Connecticut, Pennsylvania, Delaware, and greater Philadelphia with medical weight loss, sleep medicine, and long-term maintenance support.
GLP-1 specials: Affordable GLP-1 injections NYC and Philadelphia starting from $29.99/week and up for semaglutide with insurance accepted for qualifying visits, and $45/week and up for tirzepatide with insurance accepted for qualifying visits. Self-pay options start from $59.99/week and up for semaglutide and $69.99/week and up for tirzepatide.
Medical weight loss NYC | Affordable GLP-1 injections NYC | Budget GLP-1 weight loss shots Philadelphia | New Jersey medical weight loss | NYC medical weight loss | Philadelphia medical weight loss | Sleep clinic NYC | W8MD's Philadelphia GLP-1 doctor | Weight loss prescriptions NYC
Book a W8MD appointment · View GLP-1 specials
Paid promotional message. Eligibility, pricing, insurance coverage, medication availability, and results vary. Medical evaluation required.
Medical Disclaimer: WikiMD is for informational purposes only and is not a substitute for professional medical advice. Content may be inaccurate or outdated and should not be used for diagnosis or treatment. Always consult your healthcare provider for medical decisions. Verify information with trusted sources such as CDC.gov and NIH.gov. By using this site, you agree that WikiMD is not liable for any outcomes related to its content. See full disclaimer.
Credits:Most images are courtesy of Wikimedia commons, and templates, categories Wikipedia, licensed under CC BY SA or similar.
Translate page: - East Asian
中文,
日本,
한국어,
South Asian
हिन्दी,
தமிழ்,
తెలుగు,
Urdu,
ಕನ್ನಡ,
Southeast Asian
Indonesian,
Vietnamese,
Thai,
မြန်မာဘာသာ,
বাংলা
European
español,
Deutsch,
français,
Greek,
português do Brasil,
polski,
română,
русский,
Nederlands,
norsk,
svenska,
suomi,
Italian
Middle Eastern & African
عربى,
Turkish,
Persian,
Hebrew,
Afrikaans,
isiZulu,
Kiswahili,
Other
Bulgarian,
Hungarian,
Czech,
Swedish,
മലയാളം,
मराठी,
ਪੰਜਾਬੀ,
ગુજરાતી,
Portuguese,
Ukrainian
